ClinicalTrials.Veeva

Menu

Austrian Wearable Cardioverter Defibrillator Registry

M

Medical University of Graz

Status

Unknown

Conditions

Ventricular Dysfunction
Ventricular Fibrillation
Sudden Cardiac Arrest
Heart Failure
Sudden Death
Ventricular Tachycardia

Treatments

Other: Registry

Study type

Observational

Funder types

Other

Identifiers

NCT02816047
KardioScherr1

Details and patient eligibility

About

Background: The wearable cardioverter defibrillator (WCD) is an established treatment option for patients at high risk for ventricular tachycardia / ventricular fibrillation (VT/VF), either in whom this risk may only be temporarily present, or in patients at high risk for sudden cardiac death (SCD) or after VT/VF in whom an implantable cardioverter defibrillator (ICD is currently not possible for other reasons (infection, recent MI <40days, recent PCI/CABG < 3months etc.).

Methods: Comprehensive registry including all patients in Austria who received a WCD in 2010-2016.

Full description

Observational study to describe WCD indications, event rates, inappropriate shock rates and follow up (including ICD rate, shock rate, morbidity and mortality) in all Austrian WCD patients

Enrollment

450 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • patients, with a prescribed WCD according to guidelines in an austrian center

Trial contacts and locations

1

Loading...

Central trial contact

Daniel Scherr, Assoz. Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems